Drug Profile


Alternative Names: UP 11677

Latest Information Update: 21 Nov 2007

Price : $50

At a glance

  • Originator UPSA
  • Class Antiplatelets
  • Mechanism of Action Thromboxane A2 receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Thrombosis

Most Recent Events

  • 02 Sep 1997 UP 11677 is now called mipitroban
  • 29 Mar 1996 No-Development-Reported for Thrombosis in USA (Unknown route)
  • 29 Mar 1996 No-Development-Reported for Thrombosis in France (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top